Moertel Cg
- Oncology top 5%
- Colorectal Cancer Treatments and Studies 13
- Cancer Treatment and Pharmacology 6
- Hepatology top 10%
-
- Gastric Cancer Management and Outcomes 13
- Metastasis and carcinoma case studies 6
- Pathology and Forensic Medicine top 10%
- Surgery top 10%
- Colorectal and Anal Carcinomas 5
-
- Cancer therapeutics and mechanisms 7
-
- Cancer Research and Treatments 5
-
- Neuroendocrine Tumor Research Advances 5
- Co-authors
- Robert G. HahnSchutt AjSusan GalandiukWieand HsSun‐Shin ChaPemberton JhFitzgibbons RjPT Lavin
- Journals
- Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) (2 papers)PubMed (51 papers)
- Partner nations
- United States
In The Last Decade
Moertel Cg
51 papers receiving 951 citations
Peers
Comparison fields: 5 of 79
- Oncology 717
- Hepatology 95
- Pulmonary and Respiratory Medicine 326
- Pathology and Forensic Medicine 171
- Surgery 300
Countries citing papers authored by Moertel Cg
This map shows the geographic impact of Moertel Cg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Moertel Cg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Moertel Cg more than expected).
Fields of papers citing papers by Moertel Cg
This network shows the impact of papers produced by Moertel Cg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Moertel Cg. The network helps show where Moertel Cg may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Moertel Cg, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Phase II study of hycanthone in patients with advanced colorectal carcinoma. | 1983 | 4 |
| 2 | Phase II study of PALA in advanced large bowel carcinoma. | 1981 | 9 |
| 3 | Phase II trial of indicine N-oxide (INDI) in patients with advanced colorectal carcinoma. | 1981 | 7 |
| 4 | Phase II-III chemotherapy studies in advanced gastric cancer. Eastern Cooperative Oncology Group. | 1980 | 42 |
| 5 | Phase II trial of maytansine in patients with advanced colorectal carcinoma. | 1978 | 10 |
| 6 | The carcinoid syndrome--a role for hemodialysis. | 1977 | 1 |
| 7 | Walter Hubert lecture Chemotherapy of upper gastrointestinal carcinoma. | 1976 | 4 |
| 8 | Phase II studies of dianhydrogalactitol and VP-16-213 in colorectal cancer. | 1976 | 20 |
| 9 | Nitrosoureas: useful agents for the treatment of advanced gastrointestinal cancer. | 1976 | 18 |
| 10 | Phase II study of chromomycin A3 (NSC-58514) in advanced colorectal carcinoma. | 1975 | 2 |
| 11 | Phase I study of chromomycin A (NSC-58514). | 1974 | 2 |
| 12 | Treatment of advanced squamous cell carcinoma of the gastrointestinal tract with bleomycin (NSC-125066). | 1974 | 19 |
| 13 | Phase II study of cis-diamminedichloroplatinum (NSC-119875) in advanced carcinoma of the large bowel. | 1974 | 42 |
| 14 | Effect of concomitant drug treatment on toxic and therapeutic activity of 5-fluorouracil (5-FU; NSC-19893). | 1972 | 1 |
| 15 | Effect of resection of the primary neoplasm on responsiveness to chemotherapy of patients with large bowel cancer. | 1972 | 2 |
| 16 | Phase II study of bleomycin (NSC-125066) therapy for large bowel cancer. | 1972 | 3 |
| 17 | Phase II study of 5-azacytidine (NSC-102816) in the treatment of advanced gastrointestinal cancer. | 1972 | 21 |
| 18 | Comparative response of carcinoma of the rectum and carcinoma of the colon to fluorinated pyrimidine therapy. | 1969 | 4 |
| 19 | VINCRISTINE (NSC-67574) THERAPY OF ADULT PATIENTS WITH SOLID TUMORS. | 1964 | 8 |
| 20 | Comparison of rapid and slow intravenous administration of 5-fluorouracil in treating patients with advanced carcinoma of the large intestine. | 1962 | 17 |
About Moertel Cg
Moertel Cg is a scholar working on Oncology, Biotechnology and Pulmonary and Respiratory Medicine, having authored 53 papers that have together received 1.1k indexed citations. Recurring topics across this work include Gastric Cancer Management and Outcomes (13 papers), Colorectal Cancer Treatments and Studies (13 papers), Cancer therapeutics and mechanisms (7 papers), Metastasis and carcinoma case studies (6 papers), Cancer Treatment and Pharmacology (6 papers), Colorectal and Anal Carcinomas (5 papers), Cancer Research and Treatments (5 papers) and Neuroendocrine Tumor Research Advances (5 papers). The work is most often cited by research in Oncology (717 citations), Hepatology (95 citations) and Pulmonary and Respiratory Medicine (326 citations). Moertel Cg has collaborated with scholars based in United States. Frequent co-authors include Robert G. Hahn, Schutt Aj, Susan Galandiuk, Wieand Hs, Sun‐Shin Cha, Pemberton Jh, Fitzgibbons Rj, PT Lavin, O'Connell Mj and Joseph Rubin. Their work appears in journals such as Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.